Kronox Lab Sciences: Q2 FY27 Net Profit Rs. 644.03 lakhs; Indo Borax acquired 64.26%
RESULTS
◆ Monitor Closely
MEDIUM RISK
📅 Filed on BSE: 05 Nov 2026, 02:17 PM IST · BSE ID: 3747db29-006b-4bc8-82ca-09217bf55596
View Original BSE Filing (PDF)
💡
In Simple Terms
The company reported its latest financial results, and a new company, Indo Borax & Chemicals, now owns a majority 64.26% stake.
🤖 AI Summary
- Kronox Lab Sciences reported a standalone net profit of Rs. 644.03 lakhs for Q2 FY27.
- Revenue from operations for Q2 FY27 stood at Rs. 2,683.42 lakhs, down from Rs. 2,838.64 lakhs in Q1 FY27.
- Half-year net profit was Rs. 1,374.33 lakhs on revenue from operations of Rs. 5,522.06 lakhs.
- Indo Borax & Chemicals Limited acquired 64.26% of paid-up equity shares, becoming the holding company.
- Change in Board of Directors and Key Managerial Personnel effective September 29, 2026, due to change in controlling stake.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Revenue from Operations (Q2 FY27)
Rs. 2,683.42 lakhs
5.10%
Profit after Tax (Q2 FY27)
Rs. 644.03 lakhs
-3.53%
Revenue from Operations (H1 FY27)
Rs. 5,522.06 lakhs
10.84%
Profit after Tax (H1 FY27)
Rs. 1,374.33 lakhs
5.16%
Indo Borax & Chemicals Ltd. Acquired Stake
64.26%
Paid-up Equity Share Capital
Rs. 3,710.40 lakhs
🏢 How This Affects the Company
The acquisition by Indo Borax & Chemicals Limited marks a significant change in ownership, potentially leading to revised business strategies and market positioning under new control. Revenue from operations decreased sequentially from Q1 FY27 to Q2 FY27.
Net profit for Q2 FY27 was Rs. 644.03 lakhs, with a half-year net profit of Rs. 1,374.33 lakhs. The balance sheet shows total equity increased to Rs. 12,798.64 lakhs as of September 30, 2026, from Rs. 11,612.69 lakhs as of March 31, 2026.
A change in the Board of Directors and Key Managerial Personnel effective September 29, 2026, indicates potential shifts in operational leadership and strategic direction following the acquisition.
The transition to a new holding company and management may introduce integration challenges or strategic uncertainties, alongside opportunities for synergy under Indo Borax & Chemicals Limited.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders based on this filing.
👤
Who Is Affected
All shareholders are affected by the change in controlling stake, as Indo Borax & Chemicals Limited now holds 64.26% of the paid-up equity share capital, impacting governance and strategic direction.
🔍
Management Signal
The acquisition by Indo Borax & Chemicals Limited and subsequent changes in management signal a shift in corporate control and strategic leadership for Kronox Lab Sciences.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List - track these upcoming events
Q3 FY27 financial results — assess revenue and profit trends under new management.
Any further announcements regarding strategic plans by the new holding company.
Updates on changes in the Board of Directors or Key Managerial Personnel.
MEDIUM RISK
Change in controlling stake and management introduces integration risks and potential strategic shifts, alongside sequential revenue decline.
💡 Investor Takeaway
Kronox Lab Sciences reported Q2 FY27 net profit of Rs. 644.03 lakhs and revenue from operations of Rs. 2,683.42 lakhs. Half-year net profit was Rs. 1,374.33 lakhs. Indo Borax & Chemicals Limited acquired 64.26% stake, leading to changes in the Board and Key Managerial Personnel, effective September 29, 2026.
⚖️ Strengths & Concerns
✅ Positives
- Net cash generated from operating activities for the six months ended September 30, 2026, increased to Rs. 1,604.13 lakhs from Rs. 1,049.73 lakhs.
- Total Equity increased to Rs. 12,798.64 lakhs as of September 30, 2026, from Rs. 11,612.69 lakhs as of March 31, 2026.
⚠️ Concerns
- Revenue from operations decreased sequentially to Rs. 2,683.42 lakhs in Q2 FY27 from Rs. 2,838.64 lakhs in Q1 FY27.
- Profit after Tax for the quarter ended September 30, 2026, was Rs. 644.03 lakhs, down from Rs. 730.30 lakhs in Q1 FY27.
📅 Company Track Record
Kronox Lab Sciences had informed BSE on 2026-10-30 about a board meeting to consider Q2 FY27 results. An outcome of board meeting filed on 2026-11-05 also announced the acquisition of 64.26% stake by Indo Borax & Chemicals Limited and Q2 FY27 Net Profit of Rs. 644.03 lakhs.
Based on publicly available historical data. For context only.
❓ Frequently Asked Questions
What was Kronox Lab Sciences' net profit for Q2 FY27?
Kronox Lab Sciences reported a standalone net profit of Rs. 644.03 lakhs for the quarter ended September 30, 2026 (Q2 FY27).
What was the revenue from operations for Kronox Lab Sciences in Q2 FY27?
The revenue from operations for Kronox Lab Sciences in Q2 FY27 was Rs. 2,683.42 lakhs.
Which entity acquired a controlling stake in Kronox Lab Sciences?
Indo Borax & Chemicals Limited acquired Equity Shares representing 64.26% of the Paid-up Equity Share Capital of Kronox Lab Sciences Limited.
When did Indo Borax & Chemicals Limited become the holding company?
Indo Borax & Chemicals Limited became the holding company on September 29, 2026, following the transfer of equity shares.
What was Kronox Lab Sciences' net profit for the half-year ended September 30, 2026?
The net profit after tax for the six months ended September 30, 2026, was Rs. 1,374.33 lakhs.
Questions based on this BSE filing only. For information purposes.